AzTrials
AzTrials

Hip FracturesEDU-RAPIDNCT02892968

ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients

A study testing Fascia-Iliaca Block(FIB) and Femoral Nerve Block(FNB) in people with Hip Fractures and Delirium, run by Sunnybrook Health Sciences Centre at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Hip fractures are common, costly and affect older people - Canadians spend 1 billion dollars to treat hip fractures each year. Unfortunately, as many as two-thirds of hip fracture cases suffer a complication known as delirium, or acute confusion. Patients with delirium may become frightened and agitated. Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
Conditions the study is for
Hip Fractures, Delirium
What is being tested?
Fascia-Iliaca Block(FIB) and Femoral Nerve Block(FNB)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
800 participants
Where
1 siteCanada
Study dates
Sep 2016to Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • At the cluster level, ED physicians practicing at a participating site will be eligible.
  • At the patient level, all hip fractures seen by a participating ED physician will be eligible

Who cannot join

  • ED physicians who work casually (less than 0.25 Full Time Equivalent)
  • ED Physicians who are routinely using U/S guided RA for hip fracture patients, or decline participation in the trial.
  • Patients' age less than 65 years;
  • Patients who are delirious on initial assessment by ED physician or severe dementia
  • Patients with communication problems (critically ill, unconscious, language barrier despite use of secure telephone-based translation service)
  • Patients with allergies to narcotics or local anesthetic; or anticoagulant use (e.g. warfarin, dabigatran, rivaroxaban).
  • Patients with hip fractures not requiring surgery (e.g. greater trochanter avulsion) will also be excluded.

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Sunnybrook Health Sciences Center

    Toronto, Ontario, M4S 3M5

    Jacques S Lee, MD, 416-480-6100 ext. 7701, jacques.lee@sunnybrook.ca

    Jacques S Lee, MD

Other trials in Canada

About this study

Official title: ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients (EDU-RAPID) Multi-center Stepped Wedge Cluster Randomized Trial

Hip fractures are common, costly and affect older people - Canadians spend 1 billion dollars to treat hip fractures each year. Unfortunately, as many as two-thirds of hip fracture cases suffer a complication known as delirium, or acute confusion. Patients with delirium may become frightened and agitated. This in turn leads to other serious problems. Having delirium doubles the chances of dying or can increase the need for admission into a nursing home. People with delirium spend an extra week in hospital on average.

Using ultrasound to locate and 'freeze' or block specific nerves can stop hip fracture pain almost immediately, and use of this technique is known to reduce delirium when administered by Anaesthetists to patients at the time of their hip operation. Unfortunately, patients with hip fractures commonly wait hours or even days in the Emergency Department (ED) prior to their operation. Currently, these patients are given narcotic pain killers like morphine to dull their pain, as most ED physicians have not been trained in using this 'freezing' technique and Anaesthetists are rarely able to leave the operating room to administer freezing to patient in the ED.

Read more

The EDU-RAPID study will test whether training ED physicians on how to use the nerve freezing technique will reduce the number of patients who develop delirium after a hip fracture. To study this, ED physicians will be trained at 6 hospitals in small groups every 6 weeks over 18 months. The study will look at how patients who are treated by ED physician who has been trained compare to patients treated by a ED physician who has not yet been trained. Also, the study will see if the training motivates ED physicians to use the block regularly.

If correct, this study could significantly improve the comfort, quality of life, and independence of patients who suffer a hip fracture. In addition, if the study shows a reduction in delirium rates, this could represent a significant cost reduction to the health care system.

Being tested
Fascia-Iliaca Block(FIB), Femoral Nerve Block(FNB)
Keywords
Regional Anesthesia Ultrasound guided, Emergency Department, Knowledge to Practice Intervention
Medical subject headings
Hip Fractures, Delirium, Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fascia-Iliaca Block(FIB)Procedure or surgery

    The target of the FIB is the potential space between the fascia iliaca and the iliacus muscle, at least 4 cm lateral to the Femoral artery. This is neither a drug nor a device.

  • Femoral Nerve Block(FNB)Procedure or surgery

    The target of the FNB technique is the intersection of the fascia iliaca and the femoral nerve. This is neither a drug nor a device.

Study groups in NCT02892968
Study groupRoleWhat they receive
U/S Guided Regional AnesthesiaExperimentalFascia-Iliaca Block(FIB) Femoral Nerve Block(FNB) All participating emergency physicians (EPs) will be randomly assigned to the order they receive training in a stepped wedge design. Thus all EPs will begin the trial as "control physicians". EPs will then be trained to use two approaches to ultrasound (U/S) guided regional anesthesia, the fascia iliaca and femoral nerve blocks. Which block that will be used will be randomly determined at the individual patient level
Receives: Procedure: Fascia-Iliaca Block(FIB); Procedure: Femoral Nerve Block(FNB)
Current Local Standard AnalgesiaNo interventionAll participating emergency physicians (EPs) will be randomly assigned to the order they receive training in a stepped wedge design. Thus all EPs will begin the trial as "control physicians". Physicians who are in the control group will provide current local standard of analgesic care for hip fracture patients such as the use of IV opiods with supplemental acetaminophen and non-steroidal anti-inflammatory agents until they receive training.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Overall rate of incident delirium

    Measured: Time of injury to post-injury day 7

  2. Time to onset of incident delirium

    Measured: Time of injury to post-injury day 7

Secondary outcomes (12)
  1. The rate of regional anesthesia use by intervention physicians for hip fracture patients

    Measured: Time of injury to operation to maximum of 7 days

  2. Time to perform the block

    Measured: Time block started to completion to maximum of 2 hours

  3. Pain Severity on 0-10 Numeric Rating Scale as assessed by treating MD or Nurse after administration of regional anesthesia

    Measured: 30 minutes and 60 minutes after administration of regional anesthesia

  4. Numeric Rating Scale (1-5) Effectiveness of block (pain reduction measured)at 30 minutes

    Measured: 30 minutes after administration of regional anesthesia

  5. Supplementary narcotic analgesics used pre-operatively, measured in morphine equivalent units

    Measured: Time of Injury to operation measured to a maximum of 7 days

  6. Maximum severity of delirium using the validated Delirium Index (DI)

    Measured: Time of injury to post-injury day 7

  7. Cognitive Assessment Method (CAM) status (CAM + or CAM -) measurement at hospital discharge

    Measured: Admission to Discharge to a maximum of 100 days

  8. Complications from the regional anesthesia including hematoma and persistent nervous dysfunction

    Measured: Time of injury to post-injury day 7

  9. Adverse events, including in-hospital falls, cardiovascular events and deaths; Hospital length of stay

    Measured: Time of injury to 1 year follow-up

  10. Functional status measured using Older Americans' Resources and Services (OARS) Activities of Daily Living Questionnaire at 1 month and 1 year follow-up

    Measured: 1 month and 1 year follow-up from Time of Injury

  11. Proportion of patients who return to independent living at discharge

    Measured: Admission to Discharge to a maximum of 1 year

  12. Mortality within 1 year post-operatively

    Measured: 1 year follow-up from time of injury

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Sep 2016 (estimated)
  2. Study startSep 2016
  3. Primary completionSep 2020 (estimated)
  4. Study completionDec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
800 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02892968
Sponsor's protocol ID
201503MOP
Acronym
EDU-RAPID
Status last verified
Sep 2016
First submitted
9 Aug 2016
Last updated
8 Sep 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Lee JS, Chenkin J, Simard R, Bhandari T, Woo MY, Perry JJ, Eagles D, Wong C, McRae AD, Lang E, Newbigging J, Sivilotti MLA, Chernoff I, Borgundvaag B, McLeod SL, Melady D, Kiss A, Emond M. Ultrasound-Guided Regional Anesthesia by Emergency Physicians for Hip Fractures and Delirium: A Randomized Clinical Trial. JAMA Netw Open. 2025 Dec 1;8(12):e2549337. doi: 10.1001/jamanetworkopen.2025.49337.

    PubMed 41396601
  • Lee JS, Bhandari T, Simard R, Emond M, Topping C, Woo M, Perry J, Eagles D, McRae AD, Lang E, Wong C, Sivilotti M, Newbigging J, Borgundvaag B, McLeod SL, Melady D, Chernoff L, Kiss A, Chenkin J. Point-of-care ultrasound-guided regional anaesthesia in older ED patients with hip fractures: a study to test the feasibility of a training programme and time needed to complete nerve blocks by ED physicians after training. BMJ Open. 2021 Jul 5;11(7):e047113. doi: 10.1136/bmjopen-2020-047113.

    PubMed 34226222
  • Guay J, Kopp S. Peripheral nerve blocks for hip fractures in adults. Cochrane Database Syst Rev. 2020 Nov 25;11(11):CD001159. doi: 10.1002/14651858.CD001159.pub3.

    PubMed 33238043

Questions about this trial

What is this clinical trial studying?

A study testing Fascia-Iliaca Block(FIB) and Femoral Nerve Block(FNB) in people with Hip Fractures and Delirium, run by Sunnybrook Health Sciences Centre at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Overall rate of incident delirium (time frame: Time of injury to post-injury day 7). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02892968, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in